Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$4.32
-1.26%
Mkt Cap $55.94M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+15.9%
Consensus $5.00 vs current $4.32
NASDAQ·Healthcare·Biotechnology
$4.32
-1.26%
Mkt Cap $55.94M
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
+15.9%
Consensus $5.00 vs current $4.32